Cargando…

Taming the Huntington’s Disease Proteome: What Have We Learned?

Mass spectrometry (MS) is a physical technique used to identify specific chemicals and molecules by precise analysis of their mass and charge; this technology has been adapted for biological sciences applications. Investigators have used MS to identify differential expressions of proteins in Hunting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seeley, Connor, Kegel-Gleason, Kimberly B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293646/ https://www.ncbi.nlm.nih.gov/pubmed/33998547 http://dx.doi.org/10.3233/JHD-200465

Ejemplares similares

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
por: Tousley, Adelaide, et al.
Publicado: (2016)

Taming Nuclear Power. What have we learned from the Fukushima disaster?
por: Basdevant, Jean-Louis
Publicado: (2011)

Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?
por: Scheuing, Lisa, et al.
Publicado: (2014)

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum
por: Iuliano, Maria, et al.
Publicado: (2021)

Large Animal Models of Huntington’s Disease: What We Have Learned and Where We Need to Go Next
por: Howland, David, et al.
Publicado: (2020)

HIV and Proteomics: What We Have Learned from High Throughput Studies
por: Grabowska, Kinga, et al.
Publicado: (2020)

Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
por: Chugh, Shaan, et al.
Publicado: (2010)

What do we know about Late Onset Huntington’s Disease?
por: Chaganti, Sai S., et al.
Publicado: (2017)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

Qualitative research on community experiences in large HIV research trials: what have we learned?
por: Camlin, Carol S, et al.
Publicado: (2018)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Endometriosis and Reproduction: What We Have Learned
por: Garcia-Fernandez, Jaime, et al.
Publicado: (2020)

In the aftermath of the Fusarium keratitis outbreak: What have we learned?
por: Epstein, Arthur B
Publicado: (2007)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
por: Miller, Virginia M., et al.
Publicado: (2019)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Robotic Prostatectomy: What We Have Learned and Where We Are Going
por: Lee, David I.
Publicado: (2009)

COVID-19 and heart disease in children: What have we learned?
por: Kadiyani, Lamk, et al.
Publicado: (2023)

School Asthma Care During COVID-19: What We Have Learned and What We Are Learning
por: Abrams, Elissa M., et al.
Publicado: (2022)

The multitubulin hypothesis revisited: what have we learned?
Publicado: (1987)

Drosophila Models of Tauopathies: What Have We Learned?
por: Gistelinck, Marc, et al.
Publicado: (2012)

Cell‐specific ablation in the testis: what have we learned?
por: Smith, L. B., et al.
Publicado: (2015)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Proteomics of Rice—Magnaporthe oryzae Interaction: What Have We Learned So Far?
por: Meng, Qingfeng, et al.
Publicado: (2019)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Vieira, Jose Gilberto H.
Publicado: (2012)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

SARS: What have we learned?
Publicado: (2003)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

What have we learned from brucellosis in the mouse model?
por: Grilló, María-Jesús, et al.
Publicado: (2012)

Residual macrovascular risk in 2013: what have we learned?
por: Fruchart, Jean-Charles, et al.
Publicado: (2014)

Cerebral cortex expansion and folding: what have we learned?
por: Fernández, Virginia, et al.
Publicado: (2016)

Two decades with omalizumab: what we still have to learn
por: Incorvaia, Cristoforo, et al.
Publicado: (2018)

Severe COVID-19: what have we learned with the immunopathogenesis?
por: Bordallo, Bruno, et al.
Publicado: (2020)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Recent advances in pruritus - what we have learned and where are we headed
por: Yosipovitch, Gil
Publicado: (2010)

Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?
por: Gerlach, Aaron C., et al.
Publicado: (2010)

Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington’s Disease
por: Tousley, Adelaide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibt9bqjdv5cfed66qd5hmpfsed